It is well established that important differences exist greater than any other disease process. The specific effect between women and men with regard to the function and of age is discussed and gender differences in plasma lipids diseases of the cardiovascular system. Women appear to be are highlighted to explain some of the differences [2] . protected from the most common form of cardiovascular Wenger [3] summarises current issues in the presentation, disease, coronary heart disease, when compared to men.
investigation and treatment of coronary heart disease in The reason(s) for this apparent protection in women are not women and focuses on the specific management and fully understood and may not solely be related to hormonal assessment of coronary heart disease in women. Cigarette differences. Data generated from epidemiological studies smoking as a risk factor for coronary heart disease in and basic science research about steroid hormone receptors women is reviewed by Bolego et al. [4] reminding us that and ion channels in cells provide evidence for distinct it is more detrimental in women than men. The importance differences with regard to gender. Despite a wealth of of education for preventive efforts is stressed. The effect of surrogate endpoint and observational data suggesting hora recently recognised cardiovascular risk factor, homomones may play a cardioprotective role in women, clinical cysteine is reviewed by Dimitrova et al. [5] and the same trials have yielded unexpected findings and at this time do group demonstrates the beneficial effect of oestrogen on not provide evidence to assert that hormone replacement homocysteine-induced endothelial injury in male rats [6] . therapy reduces the risk of cardiovascular events in
The mechanisms appear to involve glutathione and women. We hope that this series of articles in the Spotlight glucose-6-phosphate dehydrogenase activity. issue will highlight some of the interesting gender differences in cardiovascular disease. We are pleased to present both invited reviews and original data.
Endothelial function, atherosclerosis and coronary The issue is divided into five sections covering a number artery function of topics:
There is a wealth of information on the effect of gonadal hormones, endothelial function and vascular reactivity 1. Gender and risk factors for cardiovascular disease reviewed by Sader and Celermajer [7] . An original paper by Chan et al.
[10] describes how isoproterenol enhances The issue begins with an overview of coronary heart estradiol-induced relaxation via endothelium-derived nitric disease comparing differences in risk factors between men oxide and cyclic-AMP, a novel mechanism. Nakano et al. and women, with an emphasis on menopause and car-
[11] discuss the effect of oestrogen on platelet function in diovascular risk [1] . It is salutary to consider that most postmenopausal women. One of the possible detrimental women are unaware that, particularly in later ages, their effects of oestrogen on the cardiovascular system is an risk of suffering from or dying of coronary heart disease is adverse action on prothrombosis. These authors report an anti aggregatory effect on platelets supporting a potential on the effects of gonadal hormones on transmural disperOne hypothesis that has been advanced to explain the sion of calcium currents in rabbit myocytes using patch discrepant findings between clinical trials and other forms clamp techniques are also presented [22] . The effect of of evidence is that the trials completed to date have treated gender on repolarization in ventricular myocytes is prewomen who are decades past the menopause. It may be sented by Wu and Anderson [23] , and finally, an original that to be effective, therapy needs to be initiated closer to paper by Conrath et al. [24] describes gender differences in the time of menopause or before vascular disease is well the long QT syndrome and the effects of beta-blockade. established. The diversity of the effects of sex steroids on
This Spotlight on Gender issue should be thought cellular function is emphasised in a paper by Stork et al.
provoking and we are delighted that we are able to publish [12] showing that oestrogen in postmenopausal women original data as well as reviews on important cardiovascureduces levels of monocyte chemoattractant protein-1. This lar gender related topics. Women have often been excluded is another potential mechanism by which oestrogen may from large cardiovascular trials, but recent efforts to reduce atheroma development. Elegant studies by White et address gender specific health issues has dramatically al. [13] demonstrate direct cellular effects of oestrogen on improved the amount of data available to help guide calcium gating in isolated human coronary smooth muscle.
physicians to optimise the cardiovascular health of their A mouse model of ischaemia-reperfusion myocardial female patients. Further research is needed, as there are injury and the role of gender in this process is presented by important questions, which still need to be answered with Cross et al. [14] in an original paper. Finally a cardiologiregard to the complex interplay between gender, hormones cal condition although rare, but which is most common in and function of the cardiovascular system. postmenopausal females, cardiac Syndrome X, is reviewed by Kaski [9]. [19] . Cardiac fibroblast proliferation and the effects of[ 12] Stork S, Baumann K, van Schacky C, Angerer P. The effect of oestrogen and progesterone is investigated in an original 17b-estradiol on mcp-1 serum levels in postmenopausal woman.
Gender and the myocardium
paper by Mercier et al. [20] . 
